Physician profile
Claudia L Buser
NPI 1326224718
$3,177.71
in general payments reported to CMS, 2019-2025
18 companies · $780 in 2025
The $780 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $66.66 · 2021: $67.13 · 2022: $833 · 2023: $655 · 2024: $409 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,843.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $963.95 | 2022-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $508.68 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $435.70 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Visioneering Technologies, INC. | $197.24 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $191.38 | 2019 | |
| Alcon Vision LLC | $114.66 | 2020-2025 | Tryptyr, Rocklatan, Eysuvis |
| Abbvie INC. | $114.48 | 2023-2025 | Vuity, Lumigan |
| Oyster Point Pharma, INC. | $111.10 | 2022-2025 | Tyrvaya, Ryzumvi |
| Rxsight INC | $103.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $101.28 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $99.00 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $84.10 | 2024-2025 | Vevye |
| Thea Pharma INC. | $58.45 | 2023-2025 | Iyuzeh |
| Allergan, INC. | $22.73 | 2022 | |
| Coopervision INC. | $20.39 | 2025 | Misight Contact Lens |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $18.36 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Buser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.